Investors & Funders in Health Tech

De-Risk Your Health Tech Portfolio with Patient-Proven Insights

Get faster product-market fit, long-term ROI and better outcomes backed by real patient stories and AI-driven validation.

De-risk your portfolioStart a conversation

Trusted by

The Risks You Can’t Ignore

Sky-High Failure Rates

98% of digital health startups flop, often due to misalignment with real patient needs.

Due Diligence Challenges

Difficulty assessing patient-market fit and regulatory viability

Burnout before Breakthrough

Without the right frameworks, startups spend energy chasing complexity instead of building traction.

The Hidden Causes

Why Startups Really Fail

Most failures aren’t about weak tech - they’re about blind spots. Startups often validate against market assumptions instead of patient realities. Without real-world alignment, even the best-funded product will stall in adoption.
Learn More

Why Due Diligence Falls Short

Traditional diligence looks at numbers, not narratives. Clinical data, TAM slides, and regulatory checklists rarely reveal if people will actually use the solution. Investors miss hidden risks - like cultural barriers, workflow friction, or trust gaps that only surface when patients are part of the process.
Learn More

Why Energy Gets Wasted

Founders burn out chasing complexity because they lack a framework. Without a map, they build features no one asked for, pivot too late, and confuse investors with unproven stories. The result: momentum dies before the breakthrough.
Learn More

Free Download

The Investor’s Playbook for Avoiding Health Tech Failures

Ensure the companies you fund are designed to last with frameworks that reduce failure risk and lead to scalable growth pathways.


Phicil-Itate Change

Phicil-itate Change is an innovation studio that transforms high-potential healthcare concepts into scalable, radically patient-centered solutions.
Learn More

SEEDS Innovation Framework

A structured methodology that helps health tech innovations accelerate product-market fit by integrating patient insights, aligning with healthcare systems, and designing for real-world adoption.
Learn More

Frequently Asked Questions

The Innovation Readiness Assessment is a proprietary due diligence tool that evaluates early-stage health tech startups across five critical domains: patient-market fit, health equity alignment, usability, regulatory foresight, and adoption readiness. It’s based on our SEEDS Innovation Framework and incorporates real patient narrative data from our Listen Phirst™Platform to highlight risks traditional diligence misses.

By surfacing gaps in clinical usability, patient trust, and systemic fit, we help you avoid costly misalignments that lead to product failure. You’ll get an objective lens on where a startup needs to pivot, validate further, or may not be ready for funding at all—before you commit capital.

Unlike standard ESG checklists or retrospective data tools, we use multilingual, AI-analyzed patient narratives and blockchain-based consent systems to ensure authentic, inclusive, and real-time insights. Our SEEDS Innovation Framework is specifically designed to uncover risks related to equity, adoption, and scalability that other tools overlook.

Our tools work across stages but are especially valuable for early-stage (Pre-Seed to Series B) health tech investors, accelerators, and corporate venture arms that want to improve their diligence process, reduce risk, and meet ESG or impact investing mandates with real-world data.

Let’s De-Risk Your Health Tech Portfolio

Get a personalized Innovation Readiness Assessment that highlights red flags, ESG gaps,

and product-market misalignments – before you write the next check.

Start a Conversation
with Sheila